Earnings Feed
Start Free
$SUPN·4

SUPERNUS PHARMACEUTICALS INC · Mar 26, 5:33 PM ET

SUPERNUS PHARMACEUTICALS INC 4

4 · SUPERNUS PHARMACEUTICALS INC · Filed Mar 26, 2015

Insider Transaction Report

Form 4
Period: 2015-03-24
SUPERNUS PHARMACEUTICALS INCSUPN
Bryan Jones W.
VP of Business Development
Transactions
  • Exercise/Conversion

    Common Stock

    2015-03-24$2.56/sh+25$64→ 69,880 total
  • Exercise/Conversion

    Common Stock

    2015-03-24$3.36/sh+1,875$6,300→ 69,855 total
  • Sale

    Common Stock

    2015-03-24$12.00/sh−1,900$22,800→ 67,980 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2015-03-24−1,875→ 625 total
    Exercise: $3.36Exp: 2020-02-10→ Common Stock (1,875 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2015-03-24−25→ 37,475 total
    Exercise: $2.56Exp: 2020-11-02→ Common Stock (25 underlying)
Footnotes (3)
  • [F1]Transaction made pursuant to a Rule 10b5-1 trading plan adopted on April 21, 2014.
  • [F2]The option vested in four equal annual installments beginning on February 10, 2011.
  • [F3]The option vested in four equal annual installments beginning on November 2, 2011.

Documents

1 file
  • 4
    a4.xmlPrimary

    4